Laurus Labs DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.76×	0.75×	0.74×	0.69×	0.72×
	0.93×	0.91×	0.77×	0.60×	0.87×
	24.1%	19.0%	11.3%	7.8%	21.0%
	0.69×	0.69×	0.63×	0.63×	0.83×
	1.86×	1.94×	2.03×	2.04×	1.89×
	21.9%	17.4%	8.2%	4.1%	20.6%
	18.2%	18.2%	8.4%	3.9%	21.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LAURUSLABS₹2,244.00

Laurus Labs Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB GLAND MANKIND BIOCON ALKEM LUPIN FORTIS GLENMARKMcap ₹1.21L Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.72	0.69	0.74	0.75	0.76
Interest Burden (Pretax/EBIT) ×	0.87	0.60	0.77	0.91	0.93
EBIT Margin %	20.99	7.79	11.26	19.05	24.12
Asset Turnover ×	0.83	0.63	0.63	0.69	0.69
Financial Leverage (Assets/Equity) ×	1.89	2.04	2.03	1.94	1.86
ROE (5-step product, year-end total equity) %	20.63	4.13	8.24	17.45	21.89
ROE (owners' profit / average owners' equity) %	21.39	3.94	8.35	18.19	18.19

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.